Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Coronary Artery Disease
83%
ST Segment Elevation Myocardial Infarction
68%
Cardiovascular System
66%
Rapamycin
64%
Platelet
60%
Primary Percutaneous Coronary Intervention
57%
Acute Coronary Syndrome
56%
Myocardial Infarction
54%
Acetylsalicylic Acid
51%
Antiplatelet
48%
Coronary Angiography
41%
Umirolimus
38%
Cardiology
37%
Drug-Eluting Stent
35%
Diabetes
35%
Atrial Fibrillation
31%
Diabetes Mellitus
30%
Revascularization
29%
Thrombocyte Aggregation
26%
Target Lesion
25%
Stent Thrombosis
25%
Cardiovascular Disease
24%
Acute Heart Infarction
24%
Thrombocyte Function
24%
Antithrombotic
24%
Thrombosis
24%
Zotarolimus
22%
Bleeding
22%
Patient with Diabetes
21%
Fractional Flow Reserve
20%
Heart Muscle Revascularization
19%
Angioplasty
18%
Randomized Controlled Trial
18%
Everolimus
18%
Heart Death
18%
Angiography
17%
Hazard Ratio
17%
Odds Ratio
17%
Ischemic Heart Disease
17%
Apoplexy
16%
Major Adverse Cardiac Event
15%
Target Lesion Revascularization
15%
CD34 Antibody
15%
Anticoagulant
15%
microRNA
15%
Major Bleeding
14%
Brain Ischemia
12%
Fibrinolysis
12%
Computed Tomography Angiography
12%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
95%
ST Segment Elevation Myocardial Infarction
83%
Acetylsalicylic Acid
74%
Antiplatelet
71%
Acute Coronary Syndrome
57%
Heart Infarction
52%
Rapamycin
47%
Bleeding
39%
Stent Thrombosis
36%
Umirolimus
36%
Atrial Fibrillation
34%
Anticoagulant Agent
34%
Clopidogrel
33%
Acute Heart Infarction
26%
Cardiovascular Disease
21%
Thrombosis
21%
CD34 Antibody
18%
Heart Death
18%
Diabetes Mellitus
17%
Infarction
15%
Brain Ischemia
15%
Heart Disease
15%
Ticagrelor
13%
Symptom
12%
Randomized Controlled Trial
12%
Ischemic Heart Disease
11%
Ischemia
11%
Antithrombotic Therapy
11%
Zotarolimus
11%
Noninferiority Trial
10%
Inflammation
10%
Placebo
9%
Clinical Trial
9%
Disease
9%
Observational Study
9%
Antithrombocytic Agent
9%
Antivitamin K
9%
Stenosis
9%
Rivaroxaban
8%
Thrombopoietin
8%
Arachidonic Acid
8%
Thromboxane
7%
Flow Cytometry
7%
Neutrophil Gelatinase Associated Lipocalin
7%
Everolimus
7%
Purinergic P2Y12 Receptor
7%
microRNA
7%
Thromboxane B2
7%
Biological Marker
7%
Major Adverse Cardiac Event
7%